Human Vaccines Administered Orally Market

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Human Vaccines Administered Orally Market aims to provide a comprehensive presentation of the global market for Human Vaccines Administered Orally, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccines Administered Orally. Human Vaccines Administered Orally Market contains market size and forecasts of Human Vaccines Administered Orally in global, including the following market information:
Global Human Vaccines Administered Orally Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Human Vaccines Administered Orally Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Human Vaccines Administered Orally companies in 2022 (%)
The global Human Vaccines Administered Orally market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rotavirus Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Vaccines Administered Orally include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Vaccines Administered Orally manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccines Administered Orally Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Human Vaccines Administered Orally Market Segment Percentages, by Type, 2022 (%)
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Global Human Vaccines Administered Orally Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Human Vaccines Administered Orally Market Segment Percentages, by Application, 2022 (%)
Public
Private
Global Human Vaccines Administered Orally Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Human Vaccines Administered Orally Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Vaccines Administered Orally revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Vaccines Administered Orally revenues share in global market, 2022 (%)
Key companies Human Vaccines Administered Orally sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Vaccines Administered Orally sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Vaccines Administered Orally, market overview.
Chapter 2: Global Human Vaccines Administered Orally market size in revenue and volume.
Chapter 3: Detailed analysis of Human Vaccines Administered Orally manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Vaccines Administered Orally in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Vaccines Administered Orally capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.